ArticleOncoTargets and therapy2016

A comparative study of idarubicin 12 mg/m(2) and 8 mg/m(2) combined with cytarabine as the first induction regimen for adult acute myeloid leukemia patients.

Li Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.